In breast cancer, SRSF1 regulates the alternative splicing of the pro-apoptotic gene BIM, which increases the expression of splice variant lacking the BH3 domain, thereby inhibiting apoptosis 63. This evidence concerns the gene SRSF1 and breast cancer.